Clinical Trial Enrollment for Phase II Heart Failure Study

February 9, 2018

Challenge

Jump-start enrollment in the US for this large international study so that early enrollment rates did not fall behind projections.

Solution

ThreeWire Chart Review™ services were conducted at selected sites to identify “known” study candidates. Radio, television, print and web advertisements were employed to identify “unknown” study candidates. All referral candidates were screened by our Patient Interaction Center® for potential referral to sites. Our Site Services group worked closely with staff at each of the participating sites to ensure rapid and efficient scheduling and screening of eligible candidates.

Results

More than 3,000 media patients were pre-screened by our Patient Interaction Center® over a 30-day period, resulting in approximately 400 referrals and 50 randomizations. Approximately 3,500 charts were reviewed at 7 sites, resulting in 104 Patient Interaction Center pre-screenings, 11 site referrals and 4 randomizations.

“Working with ThreeWire has been such a pleasure. Your entire team at ThreeWire has such a positive and “can do” attitude. I also love that you do not change order a client to death, but find creative ways to stay within the budget! I truly hope that I have the opportunity to work with your company on future studies.”
- Recruitment Lead Top 10 Pharma Company

 

Previous Flipbook
Patient Enrollment for Neurostimulation Device Study
Patient Enrollment for Neurostimulation Device Study

Challenge: meet time-sensitive enrollment goal of 496 patients in order to extend labeling for FDA-approved...

Next Flipbook
Patient Enrollment for Phase II Arthritis Drug Trial in US & Europe
Patient Enrollment for Phase II Arthritis Drug Trial in US & Europe

Challenge: Meet the one year enrollment timeline for this 216 patient study. When WCG ThreeWire was engaged...